TNFSF10 and neoplasm: Mice were randomized into five treatment groups (10 mice per group) on Day 9 post HCT116 inoculation (similar starting tumor volumes between the groups) and administered different doses of ADI-TRAIL fusion protein or vehicle control (PBS buffer) by intravenous injection.